Javascript must be enabled to continue!
Clinical Impact of Clinicopathological Characteristics of Undifferentiated Advanced Gastric Cancer in Elderly Patients
View through CrossRef
Background: Little is known about the clinicopathological findings in elderly patients with undifferentiated
advanced gastric cancer. The aim of this study was to clarify the clinical impact of clinicopathological
characteristics of those cancers in elderly patients.
Method: A total of 42 patients aged 80 years or older with advanced gastric cancer who had undergone
curative gastrectomy between 1998 and 2015 were included in this study. All patients were classified into
two principal subgroups based on histology: undifferentiated group and differentiated group. The two
groups were examined and compared with respect to the pathological findings and clinical outcomes.
Results: Of the 47 patients, 23 (49%) patients were in the undifferentiated group and 24 (51%) were in the
differentiated group. The undifferentiated cancer was less frequently located in the upper third of the
stomach than the differentiated cancer (4% vs 42%, P < 0.01). The frequency of the cancer with depth of
T4a was higher in the undifferentiated group than in the differentiated group (48% vs. 17%, P < 0.05). The
median number of metastatic lymph nodes in the undifferentiated group was more than that in the
differentiated group (3 vs. 1, P < 0.05). In short- and long-term outcome after curative gastrectomy, there
were no differences between the two groups.
Conclusion: In elderly patients, undifferentiated advanced gastric cancer may have more malignant
potential than differentiated cancer. However, by curative gastrectomy, the elderly patients with
undifferentiated advanced gastric cancer can be obtained the equivalent clinical outcome to those with
differentiated cancer.
Title: Clinical Impact of Clinicopathological Characteristics of Undifferentiated Advanced Gastric Cancer in Elderly Patients
Description:
Background: Little is known about the clinicopathological findings in elderly patients with undifferentiated
advanced gastric cancer.
The aim of this study was to clarify the clinical impact of clinicopathological
characteristics of those cancers in elderly patients.
Method: A total of 42 patients aged 80 years or older with advanced gastric cancer who had undergone
curative gastrectomy between 1998 and 2015 were included in this study.
All patients were classified into
two principal subgroups based on histology: undifferentiated group and differentiated group.
The two
groups were examined and compared with respect to the pathological findings and clinical outcomes.
Results: Of the 47 patients, 23 (49%) patients were in the undifferentiated group and 24 (51%) were in the
differentiated group.
The undifferentiated cancer was less frequently located in the upper third of the
stomach than the differentiated cancer (4% vs 42%, P < 0.
01).
The frequency of the cancer with depth of
T4a was higher in the undifferentiated group than in the differentiated group (48% vs.
17%, P < 0.
05).
The
median number of metastatic lymph nodes in the undifferentiated group was more than that in the
differentiated group (3 vs.
1, P < 0.
05).
In short- and long-term outcome after curative gastrectomy, there
were no differences between the two groups.
Conclusion: In elderly patients, undifferentiated advanced gastric cancer may have more malignant
potential than differentiated cancer.
However, by curative gastrectomy, the elderly patients with
undifferentiated advanced gastric cancer can be obtained the equivalent clinical outcome to those with
differentiated cancer.
Related Results
Analysis of Related Risk Factors and Prognostic Factors of Gastric Cancer with Bone Metastasis: A SEER-Based Study
Analysis of Related Risk Factors and Prognostic Factors of Gastric Cancer with Bone Metastasis: A SEER-Based Study
Background. Gastric cancer is among the most common malignant tumors at home and abroad, because its early symptoms are mostly insidious, which leads to distant metastasis when gas...
Small Cell Lung Cancer and Tarlatamab: A Meta-Analysis of Clinical Trials
Small Cell Lung Cancer and Tarlatamab: A Meta-Analysis of Clinical Trials
Abstract
Introduction
Tarlatamab is a Delta-like ligand 3 (DLL3) -directed bispecific T-cell engager recently approved for use in patients with advanced small cell lung cancer (SCL...
Aquaporin 3 Expression Pattern in Gastric Diseases and its significance
Aquaporin 3 Expression Pattern in Gastric Diseases and its significance
Abstract
Background
Aquaporin 3(AQP3) has been implicated in gastric intestinal metaplasia and gastric cancer, and considered as a biomarker to improve treatment strategy....
Study on the Value of miR6503-5p Combined with PGR in the Diagnosis of Early Gastric Cancer
Study on the Value of miR6503-5p Combined with PGR in the Diagnosis of Early Gastric Cancer
Objective To investigate the value of serum miRNA 6503-5p (miR6503-5p) combined with pepsinogen ratio (PGR) in the diagnosis of early gastric cancer. Methods: 94 patients (gastric ...
Risk factors for gastric cancer and related serological levels in Fujian, China: hospital-based case–control study
Risk factors for gastric cancer and related serological levels in Fujian, China: hospital-based case–control study
Objective
To explore the relationships between gastric cancer and serum pepsinogen I (PG I), PG II, PG I/II ratio, gastrin 17 (G-17) and
...
Abstract 199: Clinicopathological significance of stromal enzymes lysyl oxidase like 1, 3, and 4 in gastric cancer
Abstract 199: Clinicopathological significance of stromal enzymes lysyl oxidase like 1, 3, and 4 in gastric cancer
Abstract
Background and Objective:
The Lysyl oxidase (LOX) family comprises enzymes that physiologically participate in the cros...
NOURISHMENT OR NEGLECT: UNDERSTANDING THE INFLUENCE OF DIET ON THE SURGE OF GASTRIC CANCER IN PAKISTAN
NOURISHMENT OR NEGLECT: UNDERSTANDING THE INFLUENCE OF DIET ON THE SURGE OF GASTRIC CANCER IN PAKISTAN
Gastric cancer, a malignant tumour originating in the stomach, has become a pressing health concern in Pakistan. The country has witnessed a significant rise in gastric cancer case...
How to Improve Survival in Geriatric Peritoneal Dialysis Patients
How to Improve Survival in Geriatric Peritoneal Dialysis Patients
♦ Background
Recently, more elderly patients who are independent or able to live at home with the support of family are opting for continuous ambulatory periton...

